Molecular Carcinogenesis

Papers
(The median citation count of Molecular Carcinogenesis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
UBE2D1 promotes glioblastoma proliferation by modulating p21 ubiquitination60
Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance‐mediated oxaliplatin chemoresistance in colorectal cancer32
The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway32
Issue Information ‐ Ed Board31
31
The Parkinson's disease‐associated protein α‐synuclein inhibits hepatoma by exosome delivery29
Predictive Value of Neutrophil Extracellular Traps in Neoadjuvant Chemotherapy for Muscle‐Invasive Bladder Cancer28
Cover Image, Volume 62, Issue 428
Forkhead Box Q1 is a novel regulator of autophagy in breast cancer cells28
Comprehensive analysis of PTEN‐related ceRNA network revealing the key pathways WDFY3‐AS2 ‐ miR‐21‐5p/miR‐221‐3p/miR‐222‐3p ‐ TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney rena26
Potentiated effects of lactate receptor GPR81 on immune microenvironment in breast cancer26
Delta‐Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway26
Risk SNP‐mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway25
IRF2BP2 drives lymphatic metastasis in OSCC cells by elevating mitochondrial fission‐dependent fatty acid oxidation24
HNRNPC promotes estrogen receptor‐positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A‐dependent manner24
SIRT1 promotes doxorubicin‐induced breast cancer drug resistance and tumor angiogenesis via regulating GSH‐mediated redox homeostasis22
Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell‐specific molecule 1 expression21
21
RELA promotes the progression of oral squamous cell carcinoma via TFAP2A‐Wnt/β‐catenin signaling21
PTPN2 Expression in Hypopharyngeal Squamous Cell Carcinoma and Its Clinical Significance21
Hepatitis B Virus X Protein Contributes to Hepatocellular Carcinoma via Upregulation of KIAA1429 Methyltransferase and mRNA m6A Hypermethylation of HSPG2/Perlecan20
Issue Information ‐ Ed Board20
Atypical BCR‐ABL1 transcript in mixed phenotype acute leukemia with bone marrow necrosis20
Issue Information ‐ Ed Board20
Conditional deletion of mTOR discloses its essential role in early B‐cell development19
Blocking the ATR‐SerRS‐VEGFA pathway targets angiogenesis for UV‐induced cutaneous squamous cell carcinoma19
18
18
Homologous recombination repair gene mutations in colorectal cancer favors treatment of immune checkpoint inhibitors18
Correction to “Cucurbitacin B Induces Inhibitory Effects via CIP2A/PP2A/Akt Pathway in Glioblastoma Multiforme”18
VPS45 Contributes to the Progression of Hepatocellular Carcinoma by Triggering the Wnt/β‐Catenin Signaling Pathway17
Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells17
Issue Information ‐ Ed Board16
Transmembrane protein 147, as a potential Sorafenib target, could expedite cell cycle process and confer adverse prognosis in hepatocellular carcinoma15
Oncogenic fusion of CD63‐BCAR4 contributes cancer stem cell‐like properties via ALDH1 activity15
Identification of concurrent STAT3::RARA and RARA::STAT5b fusions in a variant APL case15
DNTT activation, TdT‐aided gene length mutation, and better prognosis in ATG‐based regimen allo‐HSCT in AML14
Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype14
A potential signaling axis between RON kinase receptor and hypoxia‐inducible factor‐1 alpha in pancreatic cancer14
Circ_0007429/miR‐637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC14
Transcriptional activation of S100A2 expression by HIF‐1α via binding to the hypomethylated hypoxia response elements in HCC cells13
Role of solute carrier transporters SLC25A17 and SLC27A6 in acquired resistance to enzalutamide in castration‐resistant prostate cancer13
Intratumoural heterogeneity and clone evolution of oral squamous cell carcinoma13
AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway13
YTHDF1 enhances stemness and chemoresistance in triple‐negative breast cancer cells by upregulating SIAH213
ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β‐catenin pathway13
The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF‐β receptor plus dual checkpoint inhibition maintains antitumor immune cells13
LATS‐regulated nuclear‐cytoplasmic translocation of SREBP2 inhibits hepatocellular carcinoma cell migration and invasion via epithelial–mesenchymal transition12
Immunomodulatory role of thrombin in cancer progression12
Plakophilin 1 in carcinogenesis12
12
Potential Crosstalk Between ANXA1+ Epithelial Cells and FABP4+ TAM Cells of Ferroptosis‐Related Molecular Clusters Promotes an Immunosuppressive Microenvironment in Non‐Small Cell Lung Cancer12
12
Role of hemoglobin alpha and hemoglobin beta in non‐small‐cell lung cancer based on bioinformatics analysis11
Tissue‐of‐origin for cancers determines HIF‐1 activation induced phenotypic heterogeneity11
Levels of Bile Acid Metabolism Are Associated With Alterations of Gut Microbes in Hepatocellular Carcinoma11
β‐Elemene Inhibits Adrenocortical Carcinoma Cell Proliferation and Migration, and Induces Apoptosis by Up‐Regulating miR‐486‐3p/Targeting NPTX1 Axis11
Divergence of mutational signatures in association with breast cancer subtype11
Retraction11
Associations of genetically predicted circulating insulin‐like growth factor‐1 and insulin‐like growth factor binding protein‐3 with bladder cancer risk11
KNTC1 knockdown inhibits the proliferation and migration of osteosarcoma cells by MCM211
Issue Information ‐ Ed Board11
Upregulation of collagen type X alpha 1 promotes the progress of triple‐negative breast cancer via Wnt/β‐catenin signaling10
A‐to‐I‐Edited miR‐1304‐3p Inhibits Glycolysis and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inactivating Wnt5a/ROR2 Signaling10
M2 macrophage exosome‐derived Apoc1 promotes ferroptosis resistance in osteosarcoma by inhibiting ACSF2 deubiquitination10
Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX510
Issue Information ‐ Ed Board10
Imatinib Impedes EMT and Notch Signalling by Inhibiting p300 Acetyltransferase in Breast Cancer Cells10
Doublecortin‐like kinase 1 is a therapeutic target in squamous cell carcinoma10
CYP4F11, an NRF2 Target Gene, Promotes Hepatocellular Carcinoma Cell Growth10
Stage‐specific differential expression of zinc transporter SLC30A and SLC39A family proteins during prostate tumorigenesis10
10
Predictive significance of PRR11 in prognosis and immune infiltration of glioma patients10
SNORD60 promotes the tumorigenesis and progression of endometrial cancer through binding PIK3CA and regulating PI3K/AKT/mTOR signaling pathway10
PARP5B is required for nonhomologous end joining during tumorigenesis in vivo10
Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer10
HDAC inhibitor regulates the tumor immune microenvironment via pyroptosis in triple negative breast cancer10
10
HMGB3 Contributes to Anti‐PD‐1 Resistance by Inhibiting IFN‐γ‐Driven Ferroptosis in TNBC10
Computed Tomography‐Based Radiomics and Genomics Analyses for Survival Prediction of Stage III Unresectable Non‐Small Cell Lung Cancer Treated With Definitive Chemoradiotherapy and Immunotherapy9
Integrative Bioinformatics Analysis and Experimental Study of NLRP12 Reveal Its Prognostic Value and Potential Functions in Ovarian Cancer9
Genetic variations associated with telomere length predict the risk of recurrence of non‐oropharyngeal head and neck squamous cell carcinoma9
Diosmetin: A dietary flavone as modulator of signaling pathways in cancer progression9
Review: PD‐L1 as an emerging target in the treatment and prevention of keratinocytic skin cancer9
Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell‐like properties and phosphoinositide 3‐kinas9
9
Loss of PTPRS elicits potent metastatic capability and resistance to temozolomide in glioblastoma9
Breast cancer malignancy is governed by regulation of the macroH2A2/TM4SF1 axis, the AKT/NF‐κB pathway, and elevated MMP13 expression9
A variant in CYP26B1 associated with esophageal squamous cell carcinoma risk by affecting retinoic acid metabolism9
A systems biology‐based approach to screen key splicing factors in hepatocellular carcinoma9
The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib9
HER3 V104 mutations regulate cell signaling, growth, and drug sensitivity in cancer8
Issue Information ‐ Ed Board8
MicroRNA‐505‐5p/‐3p Regulates the Proliferation, Invasion, Apoptosis, and Temozolomide Resistance in Mesenchymal Glioma Stem Cells by Targeting AUF18
circEIF3I Promotes Colorectal Cancer Metastasis by Regulating the miR‐328‐3p/NCAPH Axis8
EXPRESSION OF CONCERN: Growth Inhibition of Pancreatic Cancer Cells by Histone Deacetylase Inhibitor Belinostat Through Suppression of Multiple Pathways Including Hif, Nfkb, and Mtor Signaling 8
Regulation of programmed death ligand 1 (PD‐L1) expression by TNF‐related apoptosis‐inducing ligand (TRAIL) in triple‐negative breast cancer cells8
Cover Image, Volume 62, Issue 28
8
GRP78 promotes bone metastasis of prostate cancer by regulating bone microenvironment through Sonic hedgehog signaling8
TRIM16 E121D variant affects the risk and prognosis of hepatocellular carcinoma by modulating the Wnt/β‐catenin pathway8
Energy balance‐related factors in childhood and adolescence and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status8
Low expression of lncRNA SBF2‐AS1 regulates the miR‐302b‐3p/TGFBR2 axis, promoting metastasis in laryngeal cancer8
The HDAC2–MTA3 interaction induces nonsmall cell lung cancer cell migration and invasion by targeting c‐Myc and cyclin D18
Mitogen‐activated protein kinase‐activated protein kinase‐2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer8
Targeting Hippo/YAP in intrahepatic cholangiocarcinoma: Promising molecules in cancer therapy8
Corrigendum8
Issue Information ‐ Ed Board8
The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma8
Association of SIRT6 Expression With Risk of Pneumonitis Induced by Radiotherapy in Cancer Patients8
Benzo[a]pyrene diol epoxide‐induced transformed cells identify the significance of hsa_circ_0051488, a ERCC1‐derived circular RNA in pulmonary squamous cell carcinoma7
Deciphering CD4+ T cell‐mediated responses against cancer7
TP53 mutations in head and neck cancer7
Triiodothyronine (T3) suppresses hepatic tumorigenesis and development by inhibiting the phosphorylation of ERK7
CircSPAG16 suppresses cadmium‐induced transformation of human bronchial epithelial cells by decoying PIP5K1α to inactivate Akt7
7
BORIS variant SF2(C2/A4) promotes the malignant development of liver cancer by activating epithelial‐mesenchymal transition and hepatic stellate cells7
Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression7
Transcriptome profiling reveals that VNPP433‐3β, the lead next‐generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial–mesenchymal transition and stem cell marker7
Corrigendum7
circPPP2R4 promotes colorectal cancer progression and reduces ROS production through the miR‐646/FOXK1 axis7
HIF‐1α regulates the cell viability in radioiodine‐resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF‐κB signaling pathway7
Baicalein promotes KDM4E to induce BICD1 and inhibit triple‐negative breast cancer progression by blocking PAR1 signaling7
KCNE3 Facilitates M1 Macrophage Polarization by Suppressing the Wnt/β‐Catenin Pathway, Inhibiting Glioma Proliferation, Migration, and Invasion7
Sulforaphane impaired immune checkpoint blockade therapy through activating ΔNP63α/PD‐L1 axis in gastric cancer7
SIRT1 inhibition‐induced senescence as a strategy to prevent prostate cancer progression7
Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition6
Regulation of SELENOF translation by eIF4a3: Possible role in prostate cancer progression6
TMED3 stabilizes SMAD2 by counteracting NEDD4‐mediated ubiquitination to promote ovarian cancer6
6
NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m5C‐dependent manner6
CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c‐Raf/p‐MEK/p‐ERK signaling loop6
6
6
microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX26
ACKR3 orchestrates Hedgehog signaling to promote renal cell carcinoma progression6
Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2‐RCHY1 mediated signaling pathway6
CD137 Protein Expression Pattern Determines the Functional Role of Galectin‐9 in Colorectal Cancer6
Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis6
SRPK1 Activation Facilitates Gli3S664 Phosphorylation and Promotes Metastasis in Esophageal Squamous Cell Carcinoma6
HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway6
Associations of mitochondrial DNA copy number with incident risks of gastrointestinal cancers: A prospective case–cohort study6
Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer6
Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD‐L1 inhibition to ongoing clinical studies6
Lesser prevalence of polyps/WNT‐dysregulation and concomitant upregulation of gamma‐catenin/MYC point to alternate pathways in colorectal cancer in India6
Cover Image, Volume 63, Issue 56
Withaferin A mediated changes of miRNA expression in breast cancer‐derived mammospheres6
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma6
γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway6
Characterizing Genetic Susceptibility to Colorectal Cancer in Taiwan Through Genome‐Wide Association Study6
ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ‐proteasome pathway6
KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation6
Dysregulated BCL9 Controls Tumorigenicity and Ferroptosis Susceptibility by Binding With Nrf2 in Thyroid Carcinoma6
Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling6
Pharmacologic approaches to amino acid depletion for cancer therapy6
Corrigendum6
ZNF480 Accelerates Chemotherapy Resistance in Breast Cancer by Competing With TRIM28 and Stabilizing LSD1 to Upregulate the AKT‐GSK3β‐Snail Pathway6
5
KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder urothelial carcinoma cell proliferation and migration, inhibits apoptosis5
FAP positive cancer‐associated fibroblasts promote tumor progression and radioresistance in esophageal squamous cell carcinoma by transferring exosomal lncRNA AFAP1‐AS15
CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple‐negative breast cancer by targeting miR‐761/DACT2 signaling axis5
Hypoxia Promotes Malignant Progression of Colorectal Cancer by Inducing POSTN+ Cancer‐Associated Fibroblast Formation5
Precision therapy for cancer prevention by targeting carcinogenesis5
Drug‐target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk5
5
A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle‐related genes and miRNAs in triple‐negative breast cancer cells5
Issue Information ‐ Ed Board5
Tumor‐derived extracellular vesicles confer 5‐fluorouracil resistance in esophageal cancer via long noncoding RNA AC116025.2 delivery5
Corrigendum5
Issue Information ‐ Ed Board5
The efficacy and safety of pH‐responsive and photothermal‐sensitive multifunctional nanoparticles loaded with cryptotanshinone for the treatment of gastric cancer5
Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma5
Molecular Analysis of Genes CEBPA, NPM1, IDH1, and RUNX1 Polymorphisms as Biomarker Potential in Leukemia Patients5
NUAK family kinase 2 is a novel therapeutic target for prostate cancer5
Mass cytometry and transcriptomic profiling reveal PD1 blockade induced alterations in oral carcinogenesis5
5
G2 and S phase‐expressed‐1 induces chromosomal instability in esophageal squamous cell carcinoma cells and inhibits cell apoptosis through ROS/JNK signaling5
Issue Information ‐ Ed Board5
PKMYT1 induced by YAP/TEAD1 gives rise to the progression and worse prognosis of bladder cancer5
5
FAPhigh α‐SMAlow cancer‐associated fibroblast‐derived SLPI protein encapsulated in extracellular vesicles promotes ovarian cancer development via activation of PI3K/AKT and downs5
Issue Information ‐ Ed Board5
KIN17 promotes cell migration and invasion through stimulating the TGF‐β/Smad2 pathway in hepatocellular carcinoma5
The serine protease CORIN promotes progression of gastric cancer by mediating the ERK1/2 MAPK pathway5
Daurisoline suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting MEK1/2 kinase5
BATF promotes extramedullary infiltration through TGF‐β1/Smad/MMPs axis in acute myeloid leukemia5
Loss of SETD2‐mediated downregulation of intracellular and exosomal miRNA‐10b determines MAPK pathway activation and multidrug resistance in renal cancer5
FOXD3 suppresses epithelial–mesenchymal transition through direct transcriptional promotion of SMAD7 in esophageal squamous cell carcinoma5
Expression of Concern: Amplification of Cyclinl1 in Uterine Cervical Carcinoma Has Prognostic Implications5
Adipocytes Promote Endometrial Cancer Progression Through Activation of the SIRT1‐HMMR Signaling Axis5
CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF15
5
Rapalogs induce non‐apoptotic, autophagy‐dependent cell death in HPV‐negative TP53 mutant head and neck squamous cell carcinoma4
Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF‐β1/pERK signaling pathway4
MicroRNA‐519d‐3p antagonizes osteosarcoma resistance against cisplatin by targeting PD‐L14
Polymorphisms of acetaldehyde dehydrogenase 2 and alcohol dehydrogenase 1B on the malignant transformation of vocal cord leukoplakia: A Chinese cohort4
4
PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer4
P21‐Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells4
Glutamine, Serine and Glycine at Increasing Concentrations Regulate Cisplatin Sensitivity in Gastric Cancer by Posttranslational Modifications of KDM4A4
Case report & review: Bilateral NIFTP harboring concomitant HRAS and KRAS mutation: Report of an unusual case and literature review4
4
4
PDZ‐binding kinase aggravates pancreatic neuroendocrine neoplasm progression by activating the AKT/mTOR pathway4
Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 pathway4
Downregulation of cellular retinoic acid binding protein 1 fosters epithelial–mesenchymal transition in thyroid cancer4
A comprehensive evaluation of serum tRF‐29‐R9J8909NF5JP as a novel diagnostic and prognostic biomarker for gastric cancer4
Identification of Interleukin‐Related Genes Signature for Prognosis Prediction in Head and Neck Squamous Cell Carcinoma Patients4
Heterochiral dipeptide d‐phenylalanyl‐l‐phenylalanine (H‐DPhe‐LPhe‐OH) as a potential inducer of metastatic suppressor NM23H1 in p53 wild‐type and mutant ce4
The anthraquinone derivative KA‐4s reduces energy metabolism and enhances the sensitivity of ovarian cancer cells to cisplatin4
Issue Information ‐ Ed Board4
Issue Information ‐ Ed Board4
Causal Relationship Between Blood Metabolites and Prostate Cancer Risk: A Two‐Sample Mendelian Randomization Study4
Zinc Finger Protein 263 Augments Autophagy and Promotes Intrahepatic Cholangiocarcinoma Proliferation4
Integrated analysis of single cell and bulk RNA sequencing identifies CTHRC1+INHBA+CAF as drivers of colorectal cancer progression4
JD‐02, a novel Hsp90 inhibitor, induces ROS/SRC axis‐dependent cytoprotective autophagy in colorectal cancer cells4
Evaluation and Comparison of Prognostic Multigene Tests in Early‐Stage Breast Cancer: Which Is the Most Effective? A Literature Review Exploring Clinical Utility to Enhance Therapeutic Management in L4
Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway4
Expression of Concern: Alterations of RASSF1A in Premalignant Cervical Lesions: Clinical and Prognostic Significance4
circSLC25A13 acts as a ceRNA to regulate AML progression via miR‐616‐3p/ADCY2 axis4
MFSD2A Overexpression Inhibits Hepatocellular Carcinoma Through TGF‐β/Smad Signaling4
Detection of rapidly accumulating stress‐induced SUMO in prostate cancer cells by a fluorescent SUMO biosensor4
Issue Information ‐ Ed Board4
LncRNA FGD5‐AS1 Facilitates Hepatocellular Carcinoma Cell Stemness by Enhancing PKD1 mRNA Stability Through Binding With MSI24
Association of tumor mutational burden with genomic alterations in Chinese urothelial carcinoma4
GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma4
RNF7‐Mediated ROS Targets Malignant Phenotype and Radiotherapy Sensitivity in Glioma With Different IDH1 Genotypes4
Autophagy awakens—the myriad roles of autophagy in head and neck cancer development and therapeutic response4
Inhibition of endogenous hydrogen sulfide production suppresses the growth of nasopharyngeal carcinoma cells4
Integrated Genomics Reveal Potential Resistance Mechanisms of PANoptosis‐Associated Genes in Acute Myeloid Leukemia4
ARMC10 Drives Glioblastoma Progression Through Activating Notch Pathway4
A novel high‐risk model identified by epithelial–mesenchymal transition predicts prognosis and radioresistance in rectal cancer3
Oscillatory hypoxia induced gene expression predicts low survival in human breast cancer patients3
Molecular subtypes identified by multiomics analysis based on cuproptosis‑related genes precisely predict response to immunotherapy and chemotherapy in colorectal cancer3
Issue Information ‐ Ed Board3
UHRF1 plays an oncogenic role in small cell lung cancer3
Molecular and immune targets in cutaneous squamous cell carcinoma3
ABHD6 suppresses colorectal cancer progression via AKT signaling pathway3
Curcuminoid PBPD induces cuproptosis and endoplasmic reticulum stress in cervical cancer via the Notch1/RBP‐J/NRF2/FDX1 pathway3
Cip2a induces arginine biosynthesis and promotes tumor progression in non‐small cell lung cancer3
Silmitasertib in Combination With Cabozantinib Impairs Liver Cancer Cell Cycle Progression, Induces Apoptosis, and Delays Tumor Growth in a Preclinical Model3
LINC00355 promotes gastric carcinogenesis by scaffolding p300 to activate CDC42 transcription and enhancing HNRNPA2B1 to stabilize CDC42 mRNA dependent on m6A3
Issue Information ‐ Ed Board3
Ubiquitin ligase MARCH8 promotes the malignant progression of hepatocellular carcinoma through PTEN ubiquitination and degradation3
Issue Information ‐ Ed Board3
Four‐gene Prognostic Signature and Risk of Brain Metastasis of Lung Adenocarcinoma3
Corrigendum3
Tumor‐derived exosomes: Key players in non‐small cell lung cancer metastasis and their implication for targeted therapy3
Corrigendum3
Autophagy modulates FSS‐induced epithelial–mesenchymal transition in hepatocellular carcinoma cells3
0.12464809417725